-
Atomoxetine Accord 10/18/25/40/60/80/100 mg Hard Capsules – PA2315/019/001-007
Jul 9, 2024, 11:18 -
PRAC meeting highlights 8-11 July 2024
Jul 8, 2024, 00:00 -
Adverse reaction reporting - MIMS Reminder on the importance of reporting adverse drug reactions (July)
Jul 1, 2024, 00:00 -
Palmeux 75 mg and 150 mg prolonged-release suspension for injection – PA1142/040/003, 005 – One batch each
Jun 28, 2024, 12:55 -
PRAC meeting highlights 10-13 June 2024
Jun 10, 2024, 00:00 -
Kexxtone 32.4 g continuous release intraruminal device for cattle (monensin) from Elanco GmbH – Suspension of marketing authorisation
May 27, 2024, 13:05 -
iPAD CU-SP1, iPAD CU-SP1 AUTO AED – Priority 2 – Warning
May 13, 2024, 10:09 -
PRAC meeting highlights 13-16 May 2024
May 13, 2024, 00:00 -
Valproate – MIMS – New precautionary measures for male patients
May 1, 2024, 00:00 -
Implanon NXT, 68 mg, implant for subdermal use (etonogestrel) – Extension of use to allow insertion immediately postpartum and immediately postabortion
Apr 30, 2024, 14:19 -
Drug Safety Newsletter – Edition 115 – 26 April 2024
Apr 26, 2024, 00:00 -
PRAC meeting highlights 8-11 April 2024
Apr 8, 2024, 00:00 -
Closantel-containing products - Reminder to ensure accuracy of dosing in order to avoid residue violations in treated animals
Apr 3, 2024, 00:00 -
Duloxetine Accord 30 mg and 60 mg hard gastro-resistant capsules – One batch each
Apr 2, 2024, 13:15 -
Valproate (Epilim ▼) – MIMS – New precautionary measures for male patients
Apr 1, 2024, 00:00 -
Guardian™ 4 Sensor – Priority 2 – Warning
Mar 21, 2024, 00:00 -
Medical Carbon Dioxide – PA 208/006/001
Mar 15, 2024, 12:27 -
PRAC meeting highlights 4-7 March 2024
Mar 4, 2024, 00:00 -
Fluzac 20mg Capsules – PA711/110/1 – Multiple batches
Mar 1, 2024, 12:40 -
Topiramate – IMF – Introduction of a pregnancy prevention programme
Mar 1, 2024, 00:00
